Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.775
+0.002 (0.26%)
At close: Nov 20, 2024, 4:00 PM
0.785
+0.010 (1.28%)
After-hours: Nov 20, 2024, 7:51 PM EST
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $97.12 million as of November 21, 2024. Its market cap has increased by 6.14% in one year.
Market Cap
97.12M
Enterprise Value
231.35M
1-Year Change
6.14%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $97.12M, a decrease of -78.07%. That is a compound annual growth rate of -12.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 97.10M | -2.02% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 100.43M |
| Anixa Biosciences | 100.40M |
| Adagene | 98.28M |
| Monopar Therapeutics | 97.76M |
| Assembly Biosciences | 97.48M |
| Nuvectis Pharma | 95.87M |
| Coherus BioSciences | 94.65M |
| Immunic | 94.58M |